As of 9 Sept 2024, Clinuvel Pharmaceuticals total assets is $129.23M, an increase of 34.57% to 2022. This figure includes all the resources and properties owned by Clinuvel Pharmaceuticals, reflecting its financial standing at that time.
Year | Total Assets | Change |
---|---|---|
2023 | $129.23M | 34.57% |
2022 | $96.03M | 32.59% |
2021 | $72.43M | 33.14% |
2020 | $54.40M | 30.79% |
2019 | $41.59M | - |